SUBSCRIBE
SUBSCRIBE
News   Business

Neurogen Corporation Announces Appointment of Dr. John L. LaMattina to Board of Directors

February 15, 2008 | 
1 min read
BRANFORD, Conn.--(BUSINESS WIRE)--Neurogen Corporation (Nasdaq: NRGN) announced today that Dr. John LaMattina, former head of global research and development at Pfizer Inc has been appointed to the Company’s Board of Directors.
People
MORE ON THIS TOPIC
Novo Nordisk CEO Lars Fruergaard Jørgensen
C-suite
UPDATED: With Novo CEO’s Sudden Exit, Analysts Worry ‘There’s Something Pretty Wrong Here’
May 16, 2025
 · 
5 min read
 · 
Annalee Armstrong
Halftone hands shake coins out of paper money. Modern collage. Concept of inflation, bankruptcy, poverty. Financial difficulties
Deals
Bluebird’s Private Equity Buyout Boosts Upfront Cash for Shareholders
May 15, 2025
 · 
1 min read
Gentilly, France, March 21, 2021: Exterior view of the Sanofi headquarters building. Sanofi is a French multinational company specializing in the health sector
Manufacturing
Sanofi Hops Aboard US Manufacturing Blitz With $20B Commitment
May 15, 2025
 · 
2 min read
 · 
Tristan Manalac
Close the deal by shaking hands. Art collage. Orange circle in the center.
Obesity
Novo Doubles Down on Oral Obesity Meds With Septerna Deal Worth up to $2.4B
May 14, 2025
 · 
2 min read
 · 
Dan Samorodnitsky